Sunday, April 09, 2023 5:23:13 PM
-Investor Relations spoke to Licensing and confirmed plans to discuss Ipix B product in an April meeting. I have some contact with both responsible Directors in the EU company.
-Excellent potential and value in Brilacidin.
-Tested in laboratories and hospitals and humans all around the big world. Anti-bacterial and anti-viral and anti-fungal and anti-inflammatory.
-I am happy I bought an other big bag full of Ipix action below USD$.015.
-I am buying it
-development deal with a good EU partner
-1/3 owner share of a new laser surgery treatment
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171556989
“And there seems to be no sign of intelligent life anywhere.”
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
FEATURED Key Metals Surge, Unlocking New Opportunities for Savvy Mining Investors • Nov 19, 2024 8:45 AM
FEATURED Greenlane Signs New U.S. Distribution Agreement with Veriteque USA, Manufacturer of the SwabTek™ and Verifique™ Brand of Field Test Kits • Nov 19, 2024 8:34 AM
FEATURED Are we about to see a comeback? Steakholder Foods Charges Forward with New Commitments from Multiple International Players as it Transitions to Revenue Generation • Nov 18, 2024 11:56 AM
Geo-Political Tensions and Trump's Increasing Military Budgets Could Boost Demand for Actelis' Cyber Hardened Networking Tech ($ASNS) • ASNS • Nov 19, 2024 10:24 AM
CBD Life Sciences Inc. (CBDL) Closes on LOI for Potential $8 Million Revenue Cannabis Dispensary • CBDL • Nov 19, 2024 8:00 AM
North Bay Resources Announces Production of Gold Concentrate and Refinery Shipment at Bishop Gold Mill, California • NBRI • Nov 18, 2024 9:00 AM